SCHEMBL2370613

SCHEMBL2370613

NC1=NCC[C@]2(O1)c1cc(-c3cncc(F)c3)ccc1Oc1c2cc(-c2ccnc(F)c2)nc1F

nearest known ligand 0.50

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 20/20 0.50
CTSD P07339 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2370726 0.90 BACE1 (0.54) BACE1CTSD
SCHEMBL2371482 0.88 BACE1 (0.54) BACE1CTSD
SCHEMBL2371355 0.85 BACE1 (0.69) BACE1CTSD
SCHEMBL2520357 0.81 BACE1 (0.66) BACE1CTSD
SCHEMBL2528109 0.81 BACE1 (0.66) BACE1CTSD
SCHEMBL2370565 0.78 BACE1 (0.69) BACE1CTSD
SCHEMBL14808628 0.78 BACE1 (0.72) BACE1
SCHEMBL14808484 0.77 BACE1 (0.72) BACE1
SCHEMBL2369971 0.76 BACE1 (0.68) BACE1CTSD
SCHEMBL14808286 0.75 BACE1 (0.74) BACE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2547686-A1 AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE Amgen Inc. (US) 2013-01-23 EP claimed
WO-2011115928-A1 AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE AMGEN INC. (US) 2011-09-22 WO claimed
EP-2547686-A1 AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE Amgen Inc. (US) 2013-01-23 EP disclosed
WO-2011115928-A1 AMINO -DIHYDROOXAZINE AND AMINO - DIHYDROTHIAZINE SPIRO COMPOUNDS AS BETA - SECRETASE MODULATORS AND THEIR MEDICAL USE AMGEN INC. (US) 2011-09-22 WO disclosed